SHAREHOLDER ALERT: WeissLaw LLP Reminds PRSP, CMD, BPFH and ALSK Shareholders About Its Ongoing Investigations

NEW YORK, Feb. 17, 2021 /PRNewswire/ --

If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:

Joshua Rubin, Esq.

WeissLaw LLP

1500 Broadway, 16^th Floor

New York, NY  10036

(212) 682-3025

(888) 593-4771

stockinfo@weisslawllp.com

Perspecta Inc. PRSP 

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Perspecta Inc. PRSP in connection with the proposed acquisition of the company by Peraton, a portfolio company of Veritas Capital.  Under the terms of the merger agreement, PRSP shareholders will receive $29.35 in cash for each share of PRSP common stock that they hold.  If you own PRSP shares and wish to discuss this investigation or your rights, please call or visit our website: http://www.weisslawllp.com/prsp/ 

Cantel Medical Corp. CMD

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Cantel Medical Corp. CMD in connection with the proposed acquisition of the company by STERIS plc ("STERIS").  Under the terms of the agreement, STERIS will acquire CMD in a cash-and-stock transaction, pursuant to which CMD shareholders will receive $16.93 in cash and 0.33787 of a STERIS ordinary share for each CMD share, representing implied merger consideration of approximately $78.59 based upon STERIS' February 16, 2021 closing price of $182.50.  If you own CMD shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://weisslawllp.com/cmd/